Upcoming presentations and posters

Various members of UNC Gynecologic Oncology faculty will be presenting at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer in March 2017.

On Sunday, March 12, Dr. Emma Barber will receive an award for Best Clinical Poster Abstract.

Barber EL, Clarke-Pearson DL. Validity of Currently Available Venous Thromboembolism Risk Assessment Tools in Gynecologic Oncology Patients.

On Tuesday, March 14, will be the presentation ‘Surgical readmission and survival in women with ovarian cancer: Are short term quality metrics incentivizing decreased long term survival?’ by Dr. Emma Barber, Dr. Emma Rossi, and Dr. Paola Gehrig.

Also that day is the presentation, ‘Reversal of obesity-driven aggressiveness of endometrial cancer by metformin’ by Dr. Stephanie Sullivan, Dr. Arthur-Quan Tran, Dr. Leslie Clark, Dr. J. Han, Dr. L. Zhang, Dr. H Guo, Dr. Y. Yin, Dr. Dr. Chunxioa Zhou and Dr. Vickie Bae-Jump.

On Wednesday, March 15, Dr. Stephanie Sullivan will co-present “Contemporary recurrence and survival outcomes for stage IB squamous cell carcinoma of the vulva: Time to raise the bar.”

Featured Posters:
Barber EL, Van Le L, Dusetzina SB. Neoadjuvant chemotherapy versus primary debulking surgery: A propensity score matched cohort analysis of survival.

Hope E, Tarney CM, Bateman NW, Hood BL, Hamilton CA, Maxwell GL, Conrads TP, Bae-Jump VL. Differential Proteomic Analysis of Metformin Response in a Preoperative Window Clinical Trial for Endometrial Cancer.

Tran AQ, Sullivan SA, Clarke-Pearson DL, Gehrig PA. Prognostic nutritional index independently predicts survival in women with epithelial ovarian carcinoma.
Tran AQ, Sullivan SA, Lee DP, Makowski L, Bae-Jump VL. Obesity-driven metabolic effects differ in ovarian versus endometrial cancer.

Posters:
Pierce S, Desravines N, Gehrig PA. Evaluating risk for intensive care unit admission after rapid response team assessment.

Sullivan SA, Tran AQ, Xu G, Yin Y, Zhou C, Bae-Jump VL. Asparagus polysaccharide inhibits cell proliferation, adhesion and invasion in endometrial cancer cells.

Sullivan SA, Tran AQ, Cassling C, Hayes DN, Rashid N, Bae-Jump VL. Genetic variations in vulvar cancer differ from cervical cancer.

Sullivan SA, Desravines N, Liberty A, Tran AQ, Allman K, Liberty A, Gornet ME, Zorn K, Acunas J, Stone R, Bae-Jump VL, VanLe L. Surgical management versus primary radiotherapy for vulvar cancer.
Tran AQ, Sullivan SA, Cassling C, Rashid N, Hayes DN, Bae-jump VL. High frequency gene mutations in cervical cancer patients enrolled on UNCseq.

Tran AQ, Sullivan SA, Xu G, Zhang L, Zhou C, Bae-Jump VL. Repurposing topiramate as a novel targeted therapy for ovarian cancer.